From mugwort allergy to an effective vaccine?
A research team at MedUni Vienna in Austria says it has discovered key mechanisms of…
A research team at MedUni Vienna in Austria says it has discovered key mechanisms of…
Last year, the FDA rejected DBV Technologies’ peanut allergy treatment and approved that of its…
The Swiss city of Lausanne is perhaps best known as a hub of international sport,…
Allergy Therapeutics has revealed that its immunotherapy for birch pollen allergy did not result in…
The Swiss company Calypso Biotech has raised a sizeable €20M to fund its immunotherapy for…
We decided to make a visit to Espoo, Finland, this week, to visit Desentum. The…
DBV Technologies has shown in a Phase II trial that its skin patch could desensitize…
British biotech Allergy Therapeutics reports positive early-stage results for its house dust mite immunotherapy. It’s…
Allergy Therapeutics has obtained positive Phase II results for its grass pollen allergy vaccine and…
DBV Technologies' candidate could be the first treatment for allergies to cow milk after its…
ASIT Biotech, a Belgian company specialized in allergy immunotherapy, raised a total of €13.9M to…
DBV Technologies has positive safety data supporting the approval of a treatment for peanut allergy…